On 1 July 2008, Eczacıbaşı Pharmaceuticals Manufacturing successfully concluded its acquisition of a 50 percent share in Monrol Nuclear Products Industry and Trade

On 1 July 2008, Eczacıbaşı Pharmaceuticals Manufacturing successfully concluded its acquisition of a 50 percent share in Monrol Nuclear Products Industry and Trade. The new joint venture, Eczacıbaşı-Monrol Nuclear Products, unites Monrol’s expertise in nuclear medicine with the knowledge, experience, human resources and vision of the Eczacıbaşı Group, this way preparing the company for innovative achievements.

 

Eczacıbaşı-Monrol Nuclear Products began importing radiopharmaceuticals in 1995 and manufacturing products for nuclear medicine in 1997. It is now the leader of the nuclear medicine industry in Turkey.

Tüm Haberlere Git